Chemoinformaics analysis of 14, 17- Octadecadienoic acid Methyl Ester
Molecular Weight | 294.479 | nRot | 15 |
Heavy Atom Molecular Weight | 260.207 | nRig | 3 |
Exact Molecular Weight | 294.256 | nRing | 0 |
Solubility: LogS | -6.529 | nHRing | 0 |
Solubility: LogP | 7.138 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 55 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 19 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 56.005 |
nHD | 0 | BPOL | 36.713 |
QED | 0.211 |
Synth | 2.306 |
Natural Product Likeliness | 1.19 |
NR-PPAR-gamma | 0.335 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.005 |
Pgp-sub | 0.001 |
HIA | 0.009 |
CACO-2 | -4.663 |
MDCK | 0.0000205 |
BBB | 0.795 |
PPB | 0.984757 |
VDSS | 1.145 |
FU | 0.0151241 |
CYP1A2-inh | 0.829 |
CYP1A2-sub | 0.185 |
CYP2c19-inh | 0.544 |
CYP2c19-sub | 0.065 |
CYP2c9-inh | 0.452 |
CYP2c9-sub | 0.941 |
CYP2d6-inh | 0.204 |
CYP2d6-sub | 0.295 |
CYP3a4-inh | 0.804 |
CYP3a4-sub | 0.076 |
CL | 5.922 |
T12 | 0.31 |
hERG | 0.082 |
Ames | 0.043 |
ROA | 0.02 |
SkinSen | 0.977 |
Carcinogencity | 0.413 |
EI | 0.975 |
Respiratory | 0.908 |
NR-Aromatase | 0.025 |
Antiviral | No |
Prediction | 0.599226 |